HER2-positive breast cancer: Combined F-18-FDG PET and CGFL/Curie nomogram to predict pathologic complete response after preoperative chemotherapy with trastuzumab.

Affiliation auteurs!!!! Error affiliation !!!!
TitreHER2-positive breast cancer: Combined F-18-FDG PET and CGFL/Curie nomogram to predict pathologic complete response after preoperative chemotherapy with trastuzumab.
Type de publicationJournal Article
Year of Publication2019
AuteursVincent L, Jankowski C, Cortet M, Arnould L, Ladoire S, Coudert BP, Desmoulins I, Charon-Barra C, Beltjens F, Rouzier R, Reyal F, Humbert O, Cochet A, Coutant C
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume37
Date PublishedMAY 20
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/JCO.2019.37.15_suppl.e12095